Mylan settles generic Orapred ODT patent litigation with Shionogi and CIMA Labs pharmabiz.com Mylan Inc. has entered into a settlement agreement with Shionogi Inc. and CIMA Labs Inc. that will resolve patent litigation related to Prednisolone sodium phosphate orally disintegrating tablets (ODT), 10 mg, 15 mg and 30 mg. Prednisolone sodium ... Mylan in patent settlement with Shionogi, CIMA for Prednisolone ODT Mylan settles suit over asthma, allergy drug Mylan Settles Dispute Over Generic Orapred ODT |
